Breast Predictive Factors Testing — BPFT AP3
Assure accuracy in the complex molecular classification of breast tumors
The CAP’s BPFT AP3 facilitates the accurate evaluation and interpretation of breast cancer predictive factors to achieve optimal treatment plans and therapeutic outcomes.
A pathway for pathologists with mid- or high-level BPFT experience to keep current and become recognized for the many skills they have acquired through practice, the BPFT AP3 curriculum updates you on the latest in evidence-based BPF procedures, assay selection, quality management; and it improves your ability to more accurately stratify patients.
Earn up to 27.5 CME/SAM credits (includes six online and three faculty-led workshop courses).
2013 MBP/BPFT workshop dates and locations are TBD.
The CAP is working with the American Society of Clinical Oncology (ASCO) to review and update current guidelines regarding HER2 Testing. Future BPFT and MBP AP3 programs will include details regarding these updates as well as insights from Guideline authors.
Use links below to access CAP CME/SAMs available within the MBP curriculum or access a comprehensive listing of breast-related learning options in the CAP Learning Portal.
Please email us if you wish to be contacted when dates become available, or check back for future offerings.
What participants are saying
“Great experience, important learning, and most importantly, delivered helpful guidance tools (teaching materials, templates) to implement what was learned into actual reports, cases, pathology practice.”
“Excellent faculty and excellent facility for the program. I found it challenging and rewarding.”